English Polski
Vol 19, No 1-2 (2017)
Case reports
Published online: 2018-03-05

open access

Page views 923
Article views/downloads 1025
Get Citation

Connect on Social Media

Connect on Social Media

Wewnątrznaczyniowa obliteracja pierwotnych i wtórnych guzów wątroby u chorych zdyskwalifikowanych do leczenia operacyjnego (doniesienie wstępne)

Damian Ziaja1, Mariola Sznapka, Robert Kwiatkowski, Arkadiusz Leszczyna, Jacek Kostyra, Krzysztof Ziaja, Tomasz Gul, Wacław Kuczmik
Chirurgia Polska 2017;19(1-2):28-35.

Abstract

U pacjentów zdyskwalifikowanych z leczenia operacyjnego z przyczyn ogólnych, jak i miejscowej nieoperacyjności guza przerzutowego lub pierwotnego wątroby oraz po wyczerpaniu możliwości terapii onkologicznej powinno się podjąć próbę leczenia wewnątrznaczyniowego.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Maire F, Lombard-Bohas C, O'Toole D, et al. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study. Neuroendocrinology. 2012; 96(4): 294–300.
  2. Xie LL, Sun CJ, Li XD, et al. Arterial embolization of massive hepatocellular carcinoma with lipiodol and gelatin sponge. Indian J Cancer. 2015; 51 Suppl 2: e49–e51.
  3. Fong ZV, Palazzo F, Needleman L, et al. Combined hepatic arterial embolization and hepatic ablation for unresectable colorectal metastases to the liver. Am Surg. 2012; 78(11): 1243–1248.
  4. Ljungberg M, Westberg G, Vikhoff-Baaz B, et al. 31P MR spectroscopy to evaluate the efficacy of hepatic artery embolization in the treatment of neuroendocrine liver metastases. Acta Radiol. 2012; 53(10): 1118–1126.
  5. Sharma A, Kaspar M, Siddiqui M, et al. Enucleation after Embolization of Liver Failure-Causing Giant Liver Hemangioma. Am J Case Rep. 2015; 16: 563–567.
  6. Bonomo G, Della Vigna P, Monfardini L. Combined therapies for the treatment of technically unresectable liver malignancies: bland embolization and radiofrequency thermal ablation within the same session. Cardiovasc Intervent Radiol. 2012; 35(6): 1372–1379.
  7. Sato M, Tateishi R, Yasunaga H, et al. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol. 2012; 47(10): 1125–1133.
  8. Yamakado K, Miyayama S, Hirota S, et al. Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis? Jpn J Radiol. 2012; 30(7): 560–566.
  9. Hiraki T, Koizumi J, Arai Y, et al. Transcatheter arterial embolization of hypervascular tumors with HepaSphere: prospective multicenter open label clinical trial of microspheres in Japan. Jpn J Radiol. 2015; 33(8): 479–486.
  10. Del Prete M, Fiore F, Modica R, et al. Multidisciplinary Group for NeuroEndocrine Tumors of Naples. Hepatic arterial embolization in patients with neuroendocrine tumors. J Exp Clin Cancer Res. 2014; 33: 43.
  11. Topaloğlu S, Oğuz Ş, Kalaycı O, et al. Preoperative arterial embolization of large liver hemangiomas. Diagn Interv Radiol. 2015; 21(3): 222–228.
  12. Kennedy A, Bester L, Salem R, et al. NET-Liver-Metastases Consensus Conference. Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference. HPB (Oxford). 2015; 17(1): 29–37.
  13. Ji J, Gao J, Zhao L, et al. Computed tomography-guided radiofrequency ablation following transcatheter arterial embolization in treatment of large hepatic hemangiomas. Medicine (Baltimore). 2016; 95(15): e3402.
  14. Mohanty S, Rajaram R, Bilimoria KY, et al. Assessment of non-surgical versus surgical therapy for localized hepatocellular carcinoma. J Surg Oncol. 2016; 113(2): 175–180.
  15. Sanoff HK, Chang Y, Stavas JM, et al. Effectiveness of initial transarterial chemoembolization for hepatocellular carcinoma among medicare beneficiaries. J Natl Compr Canc Netw. 2015; 13(9): 1102–1110.
  16. Fang ZT, Wang GZ, Zhang W, et al. Transcatheter arterial embolization promotes liver tumor metastasis by increasing the population of circulating tumor cells. OncoTargets and Ther. 2013; 6: 1563.
  17. Park Y, Kim SUp, Kim BK, et al. Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score. Liver Int. 2016; 36(1): 100–107.
  18. Wang S, Yang C, Zhang J, et al. First experience of high-intensity focused ultrasound combined with transcatheter arterial embolization as local control for hepatoblastoma. Hepatology. 2014; 59(1): 170–177.
  19. Lin HM, Lei LM, Zhu J, et al. Risk factor analysis of perioperative mortality after ruptured bleeding in hepatocellular carcinoma. World J Gastroenterol. 2014; 20(40): 14921–14926.